Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06864689 · ClinicalTrials.gov registry record · Early Phase 1
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
A Early Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 78
- Enrollment target
NCT06864689: Clinical Trial Early Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT06864689 is a Early Phase 1 study that has not yet begun recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 78 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06864689, a Early Phase 1 study, has not yet begun recruiting, sponsored by The University of Texas Medical Branch, Galveston.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 78 participants
- Enrollment target
Study Summary
The primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Black Women (BW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a high priority Ending the HIV Epidemic (EHE) jurisdiction.
Primary Outcome
To assess whether participation in Project ROLE versus usual care will increase the willingness of Black women to access and/or use PrEP
Interventions
- BEHAVIORAL Video-log (vlog) series with videos tailored to cisgender Black women or to healthcare providers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2026-09 |
| Est. Completion | 2027-08-31 |
| Phase | Early Phase 1 |
What is known before NCT06864689 opens enrollment
NCT06864689 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 1 intervention - of which Video-log (vlog) series with videos tailored to cisgender Black women or to healthcare providers is the first listed.
NCT06864689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06864689 about?
NCT06864689 is a clinical study titled "Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.". The primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Black Women (BW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a high priority Ending t...
What is the current status of trial NCT06864689?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 78 participants. The study started on 2026-09. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT06864689?
The interventions under investigation include: Video-log (vlog) series with videos tailored to cisgender Black women or to healthcare providers (BEHAVIORAL).
Who is sponsoring clinical trial NCT06864689?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06864689's enrollment target sits among peer trials
78 300th of 2000 higher than 1,699 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia